Both RABS and isolators separate operators from the Grade A filling zone, but an isolator is a sealed enclosure decontaminated automatically, usually with vaporised hydrogen peroxide, while a RABS is a rigid barrier with glove ports that sits in a Grade B room. Under EU GMP Annex 1, open isolators need at least a Grade C background and closed isolators at least Grade D, against Grade B for RABS. Isolators give the highest sterility assurance and lower cleanroom running costs; RABS cost less upfront and suit existing Grade B suites and flexible, short campaigns.
Why the choice matters more since Annex 1
The revised EU GMP Annex 1, in operation since 25 August 2023, made barrier technology an expectation for aseptic processing. It requires a documented contamination control strategy (CCS) for the whole site, sets out what Grade A must look like, and tightens expectations on gloves, interventions and first-air protection over exposed product and components. Choosing between an isolator and a RABS is now one of the biggest decisions in any fill-finish project, because it fixes the cleanroom design, the gowning regime and the running cost for the life of the line.
How each technology works
Restricted access barrier system (RABS)
A RABS is a rigid-walled enclosure with integrated glove ports around the filling machine, with unidirectional HEPA-filtered airflow giving Grade A conditions inside. It is not hermetically sealed. In an open RABS, doors can be opened under defined, controlled conditions; in a closed RABS, doors stay closed during production. In both cases the surrounding room must be Grade B, and the interior is disinfected manually.
Isolator
An isolator provides continuous isolation of its interior from the room. It is sealed, held at a defined pressure, and bio-decontaminated by an automated, validated cycle, usually vaporised hydrogen peroxide. A closed isolator transfers materials through aseptic connections such as rapid transfer ports; an open isolator lets material pass through designed openings, sometimes called mouse holes, with airflow preventing ingress.
Side-by-side comparison
| Factor | RABS | Isolator |
|---|---|---|
| Minimum background under Annex 1 | Grade B | Grade C (open) or Grade D (closed), based on risk assessment |
| Separation from operator | Physical barrier, not sealed | Sealed, continuous isolation |
| Decontamination | Manual disinfection | Automated, validated cycle (typically VHP) |
| Interventions | Through gloves; door openings possible in open RABS under strict control | Only through gloves and transfer ports |
| Gowning and monitoring | Full Grade B gowning and monitoring around the barrier | Lighter gowning and less monitoring in a C or D room |
| Upfront cost | Lower | Higher |
| Running cost | Higher: Grade B HVAC, gowning, monitoring | Lower room costs; adds decontamination cycles and glove testing |
| Changeover and flexibility | Faster to open and change formats | Decontamination cycle adds time to each changeover |
| Fit with existing facility | Good for existing Grade B suites | Often needs layout and HVAC changes in an older suite |
| Potent or toxic products | Limited operator protection | Can be designed for both sterility and containment |
Decision guide
Choose an isolator when
- You are building a new facility and can design the room grades around the isolator.
- The line will run long campaigns of a few products, so decontamination time is a small share of the year.
- The product is potent or cytotoxic and needs operator protection as well as sterility.
- You want the lowest long-term cleanroom and gowning cost and the strongest sterility assurance argument in inspections.
Choose a RABS when
- You are upgrading an existing Grade B suite and a full redesign is not possible.
- Capital is constrained, or the timeline does not allow isolator decontamination development.
- The line runs many short campaigns, clinical batches or frequent format changes.
Whichever you choose, the selection must be justified by a documented risk assessment and linked to the CCS, with glove integrity testing and replacement frequencies defined.
What goes wrong in practice
Buying an isolator does not by itself guarantee Annex 1 compliance. Problems usually come from details: shadowing in complex layouts, airflow that behaves differently when the isolator is loaded, aeration times after decontamination that do not match production schedules, and gaps between the barrier and filling machine design. Mock-ups, early airflow modelling and smoke studies, testing the barrier together with the filling machine, and worst-case validation defined before FAT all reduce that risk. For RABS, the weak points are glove management, door-opening interventions and the discipline of manual disinfection.
Questions to ask suppliers
- Has the barrier been designed and tested together with this filling machine, and can we see smoke study videos from a similar line?
- What is the validated decontamination cycle time, including aeration, for our load?
- How are gloves tested, how often, and what is the replacement plan?
- How are first-air conditions demonstrated over open containers and stoppers?
- Which interventions are inherent to the process, and how are corrective interventions performed?
- What Annex 1 gap support is included, such as risk assessments and CCS inputs?
Companies listed in the Hello Pharma supplier directory
The Hello Pharma supplier directory lists 9 companies relevant to this guide, grouped below by machine type or category. Each name links to the company's directory entry, with a description, technologies, location and website. Companies confirmed against their websites or public listings appear first in each group.
Inclusion is not an endorsement or ranking. Many categories are inferred from company names and segments, so confirm capabilities, approvals and service reach directly with each supplier. Search all 1,232 companies.
Isolators and RABS (4)
Fabtech Technologies International Ltd.; Getinge India Pvt Ltd; Snowbell Machines Pvt Ltd; Tofflon (India) Pvt. Ltd.
Open the full entries: Sterile, injectable and liquid equipment list filtered to isolators and rabs · Engineering and validation services list filtered to isolators and rabs
Containment (6)
Getinge India Pvt Ltd; Idealin Fogging Systems; Industrial Equipwash Inc; Ozone Overseas Pvt. Ltd.; Sanosil Biotech Pvt. Ltd.; Suntec Teknopak Cleanrooms & Containments.
Open the full entries: Cleanroom, HVAC and containment list filtered to containment · Sterile, injectable and liquid equipment list filtered to containment
Frequently asked questions
Is a RABS still acceptable under EU GMP Annex 1?
Yes. Annex 1 accepts both RABS and isolators as barrier technologies for aseptic processing. A RABS must sit in at least a Grade B background, and the choice must be justified by risk assessment as part of the contamination control strategy.
What background grade does an isolator need?
Annex 1 sets a minimum of Grade C for open isolators and Grade D for closed isolators, with the final grade set by a documented risk assessment.
Why are isolators more expensive than RABS?
Isolators need a sealed, pressure-controlled enclosure, an automated and validated decontamination system, transfer ports and more development work. The extra capital is often offset over time by smaller, lower-grade cleanrooms and lighter gowning and monitoring.
Can an existing filling line be upgraded to meet Annex 1?
Often yes. Suppliers offer gap assessments and retrofits such as adding or upgrading a RABS, improving first-air protection and adding filter integrity testing. The upgrade path depends on the machine design and the room around it.
Related guides
Sources
- Annex 1 aseptic processing and barrier grade thresholds, IntuitionLabs
- Selecting barrier technologies aligned with EU GMP Annex 1, Esco Pharma
- RABS vs isolators under Annex 1, GMP Insiders
- Why isolators do not automatically ensure Annex 1 compliance, Pharmaceutical Online
- Aseptic technology advances, PDA Letter
- Annex 1 compliance for new and existing lines, Syntegon
This guide is general information to support decisions and is not engineering, validation or regulatory advice for a specific project.
